Skip to main content
OpenTrials

Clinical trial condition

Leukemia, Myeloid

Explore clinical trials studying Leukemia, Myeloid. Study availability and eligibility vary by location and protocol.

3,101 public trials 617 recruiting studies
Refine in advanced search Browse all conditions

Leukemia, Myeloid trial results

Active, Not Recruiting

French Registry of First-line Treatment of Acute Promyelocytic Leukemia

NCT02938858

Conditions
Acute Promyelocytic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +6 more
Locations
  • Centre Hospitalier d'Aix en Provence Aix-en-Provence, France
  • Groupe Hospitalier SUD Amiens, France
  • Centre Hospitalier V. Dupouy Argenteuil, France
  • Hôpital Jean Minjoz Besançon, France
View all 27 locations
View Trial Details
Active, Not Recruiting

Pharmacokinetics, Safety, and Efficacy of ASTX727 in Combination With Venetoclax in Acute Myeloid Leukemia (AML)

NCT04657081

Conditions
Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations
  • USC Norris Comprehensive Cancer Center Los Angeles, California, United States
  • Stanford University Palo Alto, California, United States
  • Yale University New Haven, Connecticut, United States
  • Baptist MD Anderson Cancer Center Jacksonville, Florida, United States
View all 34 locations
View Trial Details
Active, Not Recruiting

A Study to Assess Change in Disease State in Adult Participants With Acute Myeloid Leukemia (AML) Ineligible for Intensive Chemotherapy Receiving Oral Venetoclax Tablets in Canada

NCT05424562

Conditions
Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations
  • Tom Baker Cancer Centre /ID# 248113 Calgary, Alberta, Canada
  • University of Alberta Hospital /ID# 251531 Edmonton, Alberta, Canada
  • BC Cancer - Surrey /ID# 257515 Surrey, British Columbia, Canada
  • Vancouver General Hospital /ID# 245438 Vancouver, British Columbia, Canada
View all 20 locations
View Trial Details
Active, Not Recruiting

Safety and Efficacy of Ponatinib Followed by Imatinib in Patients With Chronic Myelogenous Leukemia in Chronic Phase

NCT04070443

Conditions
BCR-ABL Positive Chronic Myelogenous Leukemia, Bone Marrow Diseases, Chronic Disease, +12 more
Locations
  • Chu Amiens Picardie Amiens, France
  • CHU d'Angers Angers, France
  • Centre Hospitalier Annecy-Genevois Annecy, France
  • CH d'Avignon Avignon, France
View all 28 locations
View Trial Details
Active, Not Recruiting

Safety and Efficacy of FT14 Conditioning for Allogeneic HSCT in Acute Myeloid Leukemia

NCT07232953

Conditions
Acute Myeloid Leukaemia (AML), Hematologic Diseases, Hematopoietic Stem Cell Transplant (HSCT), +6 more
Locations
  • Grande Ospedale Metropolitano "Bianco Melacrino Morelli" Reggio Calabria, Calabria, Italy
  • Azienda Ospedaliera di Rilievo Nazionale Antonio Cardarelli Naples, Campania, Italy
  • Azienda Ospedaliera Universitaria di Modena Modena, Emilia-Romagna, Italy
  • Azienda Sanitaria Universitaria Friuli Centrale Udine, Friuli Venezia Giulia, Italy
View all 13 locations
View Trial Details

Related conditions